Znhit1 causes cell cycle arrest and down-regulates CDK6 expression

Zhengmin Yang1, Yonghao Cao, Xiaoyan Zhu

  • 1Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China.

Insights

Znhit1, a novel zinc finger protein, inhibits cell proliferation by down-regulating Cyclin-dependent kinase 6 (CDK6) expression. This regulation impacts T cell proliferation, highlighting Znhit1

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Immunology

Background:

  • Cyclin-dependent kinase 6 (CDK6) is crucial for G1 cell cycle progression and T cell function.
  • Znhit1 is a newly identified zinc finger protein with a conserved Zf-HIT domain.

Purpose of the Study:

  • To investigate the role of Znhit1 in cell cycle regulation.
  • To determine the effect of Znhit1 on CDK6 expression and T cell proliferation.

Main Methods:

  • Cell cycle arrest assays in NIH/3T3 cells.
  • Analysis of CDK6 gene expression and histone acetylation.
  • Validation in transgenic mouse models for T cell proliferation.

Main Results:

  • Znhit1 induced G1 cell cycle arrest in NIH/3T3 cells.
  • Znhit1 significantly down-regulated CDK6 expression through transcriptional repression.
  • Decreased histone H4 acetylation at the CDK6 promoter correlated with Znhit1 activity.
  • Znhit1 negatively regulated T cell proliferation in vivo.

Conclusions:

  • Znhit1 acts as a negative regulator of CDK6.
  • Znhit1 plays a significant role in controlling cell proliferation, particularly in T cells.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.